Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Parmer

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Regulatory Peptides|November 11, 1998
Mechanism of action of chromogranin A on catecholamine release: molecular modeling of the catestatin region reveals a beta-strand/loop/beta-strand structure secured by hydrophobic interactions and predictive of activityI Tsigelny, S K Mahata, L Taupenot, et al.
Journal of Human Hypertension|August 5, 2000
Renal kallikrein excretion: role of ethnicity, gender, environment, and genetic risk of hypertensionC K Song, J A Martinez, M T Kailasam, et al.
Life Sciences|June 23, 2000
Plasma epinephrine levels in hypertension and across gender and ethnicityJ L González-Trápaga, R A Nelesen, J E Dimsdale, et al.
Biochemical and Biophysical Research Communications|May 29, 1986
A cloned chromogranin A (CgA) cDNA detects a 2.3Kb mRNA in diverse neuroendocrine tissuesL J Deftos, S S Murray, D W Burton, et al.
Journal of Hypertension|November 1, 1994
Does lipophilicity of angiotensin converting enzyme inhibitors selectively influence autonomic neural function in human hypertension?R A Wu, M T Kailasam, J H Cervenka, et al.
Acta Histochemica. Supplementband|January 1, 1990
Circulating chromogranin A as a diagnostic tool in clinical chemistryD T O'Connor, M A Takiyyuddin, J H Cervenka, et al.
The Journal of Clinical Investigation|October 6, 2000
Processing of chromogranin A by plasmin provides a novel mechanism for regulating catecholamine secretionR J Parmer, M Mahata, Y Gong, et al.
Journal of Human Hypertension|July 1, 1994
Effects of an oral prostaglandin E1 agonist on blood pressure and its determinants in essential hypertensionM T Kailasam, M C Lin, J H Cervenka, et al.
Circulation|January 1, 1990
Is physiologic sympathoadrenal catecholamine release exocytotic in humans?M A Takiyyuddin, J H Cervenka, P A Sullivan, et al.
Neuroscience|October 1, 1993
Chromogranin A immunoreactivity in human cerebrospinal fluid: properties, relationship to noradrenergic neuronal activity, and variation in neurologic diseaseD T O'Connor, J H Cervenka, R A Stone, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Regulatory Peptides|November 11, 1998
Mechanism of action of chromogranin A on catecholamine release: molecular modeling of the catestatin region reveals a beta-strand/loop/beta-strand structure secured by hydrophobic interactions and predictive of activityI Tsigelny, S K Mahata, L Taupenot, et al.
Journal of Human Hypertension|August 5, 2000
Renal kallikrein excretion: role of ethnicity, gender, environment, and genetic risk of hypertensionC K Song, J A Martinez, M T Kailasam, et al.
Life Sciences|June 23, 2000
Plasma epinephrine levels in hypertension and across gender and ethnicityJ L González-Trápaga, R A Nelesen, J E Dimsdale, et al.
Biochemical and Biophysical Research Communications|May 29, 1986
A cloned chromogranin A (CgA) cDNA detects a 2.3Kb mRNA in diverse neuroendocrine tissuesL J Deftos, S S Murray, D W Burton, et al.
Journal of Hypertension|November 1, 1994
Does lipophilicity of angiotensin converting enzyme inhibitors selectively influence autonomic neural function in human hypertension?R A Wu, M T Kailasam, J H Cervenka, et al.
Acta Histochemica. Supplementband|January 1, 1990
Circulating chromogranin A as a diagnostic tool in clinical chemistryD T O'Connor, M A Takiyyuddin, J H Cervenka, et al.
The Journal of Clinical Investigation|October 6, 2000
Processing of chromogranin A by plasmin provides a novel mechanism for regulating catecholamine secretionR J Parmer, M Mahata, Y Gong, et al.
Journal of Human Hypertension|July 1, 1994
Effects of an oral prostaglandin E1 agonist on blood pressure and its determinants in essential hypertensionM T Kailasam, M C Lin, J H Cervenka, et al.
Circulation|January 1, 1990
Is physiologic sympathoadrenal catecholamine release exocytotic in humans?M A Takiyyuddin, J H Cervenka, P A Sullivan, et al.
Neuroscience|October 1, 1993
Chromogranin A immunoreactivity in human cerebrospinal fluid: properties, relationship to noradrenergic neuronal activity, and variation in neurologic diseaseD T O'Connor, J H Cervenka, R A Stone, et al.
Pageof 8